Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.201
-0.059 (-4.68%)
Jan 31, 2025, 4:00 PM EST - Market closed
Citius Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| FY 2024 | FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| Net Income | -21.15 | -12.7 | -10.87 |
| Stock-Based Compensation | 7.5 | 1.97 | - |
| Other Operating Activities | 0.58 | 0.58 | 1.15 |
| Change in Inventory | -2.13 | - | - |
| Change in Accounts Payable | 2.42 | 1.2 | 0.18 |
| Change in Other Net Operating Assets | 12.91 | 8.96 | 9.53 |
| Operating Cash Flow | 0.13 | - | - |
| Sale (Purchase) of Intangibles | -5 | - | - |
| Investing Cash Flow | -5 | - | - |
| Long-Term Debt Issued | 3.8 | - | - |
| Net Debt Issued (Repaid) | 3.8 | - | - |
| Other Financing Activities | 1.07 | - | - |
| Financing Cash Flow | 4.87 | - | - |
| Net Cash Flow | 0 | - | - |
| Free Cash Flow | 0.13 | - | - |
| Free Cash Flow Per Share | 0.00 | - | - |
| Levered Free Cash Flow | -1.94 | 4.55 | - |
| Unlevered Free Cash Flow | -1.94 | 4.55 | - |
| Change in Net Working Capital | -8.42 | -10.16 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.